Keybanc Analyst Initiates Coverage on ResMed with Overweight Rating and Revised Price Target
On February 6, 2024, Brett Fishbin, an esteemed analyst at Keybanc, made a noteworthy move by initiating coverage on ResMed ...
© 2024 Stocks Today
Tag: RMD
Mizuho Analyst Raises Price Target for ResMed Expresses Bullish Sentiment
On January 30, 2024, Mizuho analyst Anthony Petrone expressed his bullish sentiment towards ResMed (NYSE: RMD) by maintaining a Buy ...
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Unlocking the Future: The Rise of Open-Source FPGA Development Tools
-
The Future of Secure Communications: How Quantum-Resistant Encryption is Revolutionizing Wireless Technology
-
The Booming Market of Plant-Based Pharmaceuticals for Neurological Conditions
-
Unlocking Potential: How Recent Acquisitions in the Battery Technology Sector Are Reshaping the Energy Landscape